Oncology
12 drugs are in development for Endometrial Cancer.
- Companies
- 9
- Clinical trials
- 106
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Endometrial Cancer pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 1(9)
Phase 1/Phase 2(2)
| Drug | Company |
|---|---|
| nc410 | NextCure, Inc. (NXTC) |
| XmAb541 | Xencor Inc (XNCR) |
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| eik1005 | Eikon Therapeutics Inc. (EIKN) |
About this indication
Endometrial Cancer context
Oncology·MeSH: Endometrial Neoplasms (D016889)
Narrower concept of MeSH descriptor Endometrial Neoplasms
Prevalence
58.0 / 100K
Incidence
28.0 / 100K/yr
Compare drugs
Frequently asked questions
How many drugs are in development for Endometrial Cancer?
BioSniper tracks 12 drugs in development for Endometrial Cancer across 9 companies.
How many clinical trials target Endometrial Cancer?
There are 106 clinical trials targeting Endometrial Cancer tracked by BioSniper.
What is the prevalence of Endometrial Cancer?
The estimated prevalence of Endometrial Cancer is approximately 58.0 per 100,000 population.